 |
|
 |
| |
Hello,
The personalized medicine market is projected to grow 11% annually according to a new PharmaLive report. This year, both GSK and Pfizer have opened rare disease research units. As blockbuster drugs become elusive and the industry moves towards personalized medicine, Siren is perfectly positioned. At Siren we specialize in relationship marketing for rare disorder therapies. Sometimes we get asked, "Why so focused? Why don't you go after the big pharmaceutical brands?" Because, in addition to the unique challenges of marketing rare disorder therapies, the market is coming to us.
Siren’s strategy was recently validated by being named among the Inc. 5000, an exclusive ranking by Inc. magazine of the fastest-growing private companies in the U.S.
To keep ahead of the latest trends in this rapidly changing industry, keep reading.
|
|
 |
|
 |
 |
|
|
 |
|
|
| |
| Top SirenSong Blog Entries |
 |
|
|
 |
 |
 |
| Event Highlight |
 |
Siren Presents at Digital Pharma
Wendy White, Founder & President of Siren, and Cynthia North, Customer Marketing Director at Bayer HealthCare Pharmaceuticals, will be speaking at Digital Pharma East on “Engagement for Niche Brands: Collaborating with Patient Organizations and Establishing Trust with ePatients.” Eileen O’Brien, Siren’s Director of Search & Innovation, will be moderating a live #SocPharm Tweetchat with Dennis Urbaniak, VP, U.S. Diabetes, sanofi-aventis and Brad Pendergraph, Manager, Multi-Channel Marketing at Novartis. The conference will be held on October 18-21, 2010 in Philadelphia, PA. |
|
|
|
| |
 |
| |
| Siren News |
 |
Siren Collaborates with Lundbeck
Siren recently collaborated on an informative website for a client specializing in rare diseases, providing a comprehensive resource on Acute Intermittent Porphyria: www.AIPorphyria.com. This serious disease is rare and may present a diagnostic challenge. Content on the site includes information on the signs and symptoms of AIP, testing for the condition, recognizing triggers and working with a physician. Information tailored for healthcare professionals provides detail on a variety of topics, including pathophysiology and suggestions on managing those with AIP.
|
| |
|
|
|
|
|
| |
|
 |
|
|